This paper is in the following e-collection/theme issue:

Pharmacovigilance (171) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (215) Pharmacology and Pharmaceutics (111) Safety and Error Prevention in Health (240) Depression and Mood Disorders; Suicide Prevention (1691) Intentional Self-Harm (136)

Published on in Vol 10 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/49755, first published .
Assessing the Labeling Information on Drugs Associated With Suicide Risk: Systematic Review

Assessing the Labeling Information on Drugs Associated With Suicide Risk: Systematic Review

Assessing the Labeling Information on Drugs Associated With Suicide Risk: Systematic Review

Authors of this article:

Soo Min Jeon1 Author Orcid Image ;   HyunJoo Lim2 Author Orcid Image ;   Hyo-bin Cheon2 Author Orcid Image ;   Juhee Ryu3 Author Orcid Image ;   Jin-Won Kwon4 Author Orcid Image
Article Authors Cited by (4) Tweetations (2) Metrics

Soo Min Jeon   1 * , PharmD, PhD ;   HyunJoo Lim   2 * ;   Hyo-bin Cheon   2 , PharmD ;   Juhee Ryu   3 , PharmD, PhD ;   Jin-Won Kwon   4 , PhD

1 Jeju Research Institute of Pharmaceutical Sciences, College of Pharmacy, Jeju National University, Jeju, Republic of Korea

2 College of Pharmacy, Kyungpook National University, Daegu, Republic of Korea

3 Research Institute of Pharmaceutical Sciences, College of Pharmacy, Kyungpook National University, Daegu, Republic of Korea

4 BK21 FOUR Community-Based Intelligent Novel Drug Discovery Education Unit, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Daegu, Republic of Korea

*these authors contributed equally

Corresponding Author:

  • Jin-Won Kwon, PhD
  • BK21 FOUR Community-Based Intelligent Novel Drug Discovery Education Unit
  • College of Pharmacy and Research Institute of Pharmaceutical Sciences
  • 80 Daehak-ro
  • Daegu 41566
  • Republic of Korea
  • Phone: 82 539508580
  • Fax: 82 539508557
  • Email: jwkwon@knu.ac.kr